BBlogFlow

First-Line Dato-DXd Improves Intracranial Outcomes in Immunotherapy-Ineligible TNBC With Brain Metastases - OncLive

·10h ago

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email
Photo credit : First-Line Dato-DXd Improves Intracranial Outcomes in Immunotherapy-Ineligible TNBC With Brain Metastases | OncLive

An exploratory TROPION-Breast02 analysis showed CNS PFS and intracranial response benefits with datopotamab deruxtecan in TNBC with brain metastases. First-line datopotamab deruxtecan-dlnk (Dato-DXd; Datroway) improved central nervous system (CNS) progression-free survival (PFS) and intracranial response vs investigator's choice of chemotherapy (ICC) in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC) and baseline brain metastases for whom immunotherapy was not an option, according to an exploratory analysis of the phase 3 TROPION-Breast02 trial (NCT05374512) presented at the 2026 ESMO Congress.1 Benefit was observed in patients with and without prior CNS-directed therapy, and Dato-DXd also showed consistent systemic efficacy across PFS, overall survival (OS), and objective response rate (ORR) in this subgroup. Among patients with baseline brain metastases (n = 61), median CNS PFS was 9.5 months (95% CI, 6.9-19.3) with Dato-DXd (n = 35) vs 2.6 months (95% CI, 1.5-5.8) with ICC (n = 26; HR, 0.27; 95% CI, 0.13-0.56).

This article is an excerpt. To read the full content, visit the original source. OncLive

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

I lost my job in a primary school due to endometriosis - BBC

23 minutes agoCharlie Jones and Alice CunninghamBBC/Ant SaddingtonHayley lost her job as a teaching assistant last October, after being told she was unfit to workHayley Locksley was 11 years old when she started her periods and excruciating pain became part of her life. "I used to spend every month in the sick room at school," she says. Hayley, from Shefford, Bedfordshire, would often pass out from the pain but the doctors' advice was to take paracetamol. Aged 24, she was diagnosed with endometriosis - a condition that affects one in 10 women, where tissue similar to the lining of the womb grows outside of the uterus. Hayley says she loved her job working in a nursery, but her employers questioned whether her symptoms were real and asked her to use annual leave to cover sick days. After she had surgery for endometriosis, Hayley decided to switch to office work, due to it being less physically demanding. But her new colleagues asked why she was spending so long in the toilet. "I had to explain that my bladder sometimes did not empty fully, causing severe pain and horrendous diarrhoea. I found the questioning embarrassing and humiliating," she says.

BBC·